Ruonan Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ruonan Gao has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Libin Liu
Department of Endocrinology, Fujian Union Hospital, Fuzhou, China
3 shared publications - Kejun Wu
Department of Endocrinology, Fujian Medical University Union Hospital, Fuzhou 350001, China
2 shared publications Liqin Qi
Department of Endocrinology, Fujian Medical University Union Hospital
2 shared publicationsMengjun Zhang
Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, Fujian, China
2 shared publicationsXiaohong Liu
Department of Endocrinology, Fujian Institute of Endocrinology, Fujian Medical University Union Hospital, Fuzhou, Fujian, People's Republic of China
2 shared publicationsXiaoying Liu
Department of Endocrinology, Fujian Institute of Endocrinology, Fujian Medical University Union Hospital, Fuzhou, Fujian, People's Republic of China
2 shared publications
Latest Publications
- Open Access
- 15 May 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1844237
Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes
Background: The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) is a novel, reliable indicator of dyslipidemia. However, its association with cardiac outcomes in patients with type 2 diabetes mellitus (T2DM) following percutaneous coronary intervention (PCI) remains unclear. We investigated the association of the NHHR with the risks of major adverse cardiovascular events (MACEs) following PCI in adults with T2DM. Methods: This retrospective cohort study included 1176 adults with T2DM undergoing PCI after new-onset acute myocardial infarction between January 1, 2019, and December 31, 2023. Patients were categorized into NHHR quartiles. The relationship between the NHHR and post-PCI MACE risk was investigated using univariate and multivariate Cox regression analyses. Restricted cubic splines and smooth curve fitting evaluated the nonlinear association between the NHHR and MACE risk; receiver operating characteristic (ROC) curves determined the prognostic significance of the NHHR. Results: Over 21.0 ± 6.6 months, 246 MACEs occurred. In multivariate analysis, the NHHR was associated with MACE incidence, even after adjustments (vs. group Q1: hazard ratio [95% confidence interval] in groups Q3 and Q4, 4.00 [2.47–6.48] and 6.28 [3.92–10.05], respectively; both P < 0.05). The NHHR and MACEs were non-linearly related. Within the threshold of 3.12–5.10, every 1-unit rise in the NHHR elevated the MACE risk 1.4-fold. The area under the ROC curve of the NHHR combined with the Global Registry of Acute Coronary Events risk score was 0.84 for predicting post-PCI MACEs (sensitivity, 71.54%; specificity, 83.86%). The NHHR/MACE association persisted in subgroup analysis. No significant interactive effects were found for age, sex, hypertension, smoking, body mass index, glycated hemoglobin, and medications (P for interaction > 0.05). Conclusions: Our findings suggested a nonlinear positive association between NHHR and MACE risk in T2DM patients undergoing PCI. Routine NHHR assessment may facilitate early risk identification and tailored care for these patients.
- 15 May 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1844237
Open AccessNon-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes
Background: The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) is a novel, reliable indicator of dyslipidemia. However, its association with cardiac outcomes in patients with type 2 diabetes mellitus (T2DM) following percutaneous coronary intervention (PCI) remains unclear. We investigated the association of the NHHR with the risks of major adverse cardiovascular events (MACEs) following PCI in adults with T2DM. Methods: This retrospective cohort study included 1176 adults with T2DM undergoing PCI after new-onset acute myocardial infarction between January 1, 2019, and December 31, 2023. Patients were categorized into NHHR quartiles. The relationship between the NHHR and post-PCI MACE risk was investigated using univariate and multivariate Cox regression analyses. Restricted cubic splines and smooth curve fitting evaluated the nonlinear association between the NHHR and MACE risk; receiver operating characteristic (ROC) curves determined the prognostic significance of the NHHR. Results: Over 21.0 ± 6.6 months, 246 MACEs occurred. In multivariate analysis, the NHHR was associated with MACE incidence, even after adjustments (vs. group Q1: hazard ratio [95% confidence interval] in groups Q3 and Q4, 4.00 [2.47–6.48] and 6.28 [3.92–10.05], respectively; both P < 0.05). The NHHR and MACEs were non-linearly related. Within the threshold of 3.12–5.10, every 1-unit rise in the NHHR elevated the MACE risk 1.4-fold. The area under the ROC curve of the NHHR combined with the Global Registry of Acute Coronary Events risk score was 0.84 for predicting post-PCI MACEs (sensitivity, 71.54%; specificity, 83.86%). The NHHR/MACE association persisted in subgroup analysis. No significant interactive effects were found for age, sex, hypertension, smoking, body mass index, glycated hemoglobin, and medications (P for interaction > 0.05). Conclusions: Our findings suggested a nonlinear positive association between NHHR and MACE risk in T2DM patients undergoing PCI. Routine NHHR assessment may facilitate early risk identification and tailored care for these patients.
- Open Access
- 3 November 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (21) , 6530
Low FT3/FT4 Ratio Is Linked to Poor Prognosis of Acute Myocardial Infarction in Euthyroid Patients with Type 2 Diabetes Mellitus
This is an observational, retrospective, single-center study aimed to determine whether the free triiodothyronine (FT3) to free thyroxine (FT4) ratio was related to acute myocardial infarction (AMI) prognosis in individuals with type 2 diabetes mellitus (T2DM). A total of 294 euthyroid T2DM patients with new-onset AMI were enrolled. FT3/FT4 ratio tertiles were used to categorize patients into Group 1 (FT3/FT4 ≥ 4.3), Group 2 (3.5 ≤ FT3/FT4 < 4.3), and Group 3 (FT3/FT4 < 3.5). Major adverse cardiac events (MACE), including nonfatal myocardial infarction, target vessel revascularization (TVR), and cardiac mortality, served as the primary endpoint. Group 3 demonstrated a considerably higher incidence of MACE than the other two groups over the average follow-up duration of 21 ± 6.5 months (all p < 0.001). Multivariable Cox regression analysis showed that a low FT3/FT4 ratio was an independent risk factor for MACE after AMI (Group 1 as a reference; Group 2: hazard ratio [HR] 1.275, 95% confidence interval [CI]: 0.563–2.889, p = 0.561; Group 3: HR 2.456, 95% CI: 1.105–5.459, p = 0.027). Moreover, the area under the receiver-operating characteristic curve (AUC) indicates a good predictive value of FT3/FT4 ratio for MACE (AUC = 0.70). Therefore, in T2DM patients with AMI, a low FT3/FT4 ratio was strongly linked to poor prognosis.
- 3 November 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (21) , 6530
Open AccessLow FT3/FT4 Ratio Is Linked to Poor Prognosis of Acute Myocardial Infarction in Euthyroid Patients with Type 2 Diabetes Mellitus
This is an observational, retrospective, single-center study aimed to determine whether the free triiodothyronine (FT3) to free thyroxine (FT4) ratio was related to acute myocardial infarction (AMI) prognosis in individuals with type 2 diabetes mellitus (T2DM). A total of 294 euthyroid T2DM patients with new-onset AMI were enrolled. FT3/FT4 ratio tertiles were used to categorize patients into Group 1 (FT3/FT4 ≥ 4.3), Group 2 (3.5 ≤ FT3/FT4 < 4.3), and Group 3 (FT3/FT4 < 3.5). Major adverse cardiac events (MACE), including nonfatal myocardial infarction, target vessel revascularization (TVR), and cardiac mortality, served as the primary endpoint. Group 3 demonstrated a considerably higher incidence of MACE than the other two groups over the average follow-up duration of 21 ± 6.5 months (all p < 0.001). Multivariable Cox regression analysis showed that a low FT3/FT4 ratio was an independent risk factor for MACE after AMI (Group 1 as a reference; Group 2: hazard ratio [HR] 1.275, 95% confidence interval [CI]: 0.563–2.889, p = 0.561; Group 3: HR 2.456, 95% CI: 1.105–5.459, p = 0.027). Moreover, the area under the receiver-operating characteristic curve (AUC) indicates a good predictive value of FT3/FT4 ratio for MACE (AUC = 0.70). Therefore, in T2DM patients with AMI, a low FT3/FT4 ratio was strongly linked to poor prognosis.
- 17 August 2022
- Published by Elsevier in NeuroToxicology
- Vol. 92, 166-179
Liraglutide reduces oxidative stress and improves energy metabolism in methylglyoxal-induced SH-SY5Y cells
- 17 August 2022
- Published by Elsevier in NeuroToxicology
- Vol. 92, 166-179
Liraglutide reduces oxidative stress and improves energy metabolism in methylglyoxal-induced SH-SY5Y cells
- 1 February 2022
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 542, 111529
Glucagon-like peptide-1 analogs mitigate neuroinflammation in Alzheimer's disease by suppressing NLRP2 activation in astrocytes
- 1 February 2022
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 542, 111529
Glucagon-like peptide-1 analogs mitigate neuroinflammation in Alzheimer's disease by suppressing NLRP2 activation in astrocytes
- 1 April 2021
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 526, 111192
Recurrent non-severe hypoglycemia aggravates cognitive decline in diabetes and induces mitochondrial dysfunction in cultured astrocytes
- 1 April 2021
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 526, 111192
Recurrent non-severe hypoglycemia aggravates cognitive decline in diabetes and induces mitochondrial dysfunction in cultured astrocytes